Back to results
US 2003/0153743 A1Published application
Processes for the synthesis of oligomeric compounds
OwnerMuthiah Manoharan, Andrei Guzaevinventors
Life of this patent
Estimating the term…
Abstract
Methods for the preparation of oligonucleotides having bioreversible phosphate blocking groups are disclosed. The oligonucleotides are prepared utilizing amidite type chemistry wherein the bioreversible phosphorus protecting group is formed as an integral part of the amidite reagent.
Claims56
A method for preparing an oligomeric compound comprising a moiety having the Formula I:
- 32
- wherein:
- Z is aryl having 6 to about 14 carbon atoms or alkyl having from one to about six carbon atoms;
- Y1 is O or S;
- Y2 is O or S;
- Y3 is C(═O) or S;
- q is 2 to about 4;
- R1 is H, OH, F, or a group of formula R7—(R8)n;
- R7 is C3-C20 alkyl, C4-C20 alkenyl, C2-C20;
- alkynyl, C1-C20 alkoxy, C2-C20 alkenyloxy, or C2-C20 alkynyloxy;
- R8 is hydrogen, amino, protected amino, halogen, hydroxyl, thiol, keto, carboxyl, nitro, nitroso, nitrile, trifluoromethyl, trifluoromethoxy, O-alkyl, S-alkyl, NH-alkyl, N-dialkyl, O-aryl, S-aryl, NH-aryl, O-aralkyl, S-aralkyl, NH-aralkyl, N-phthalimido, imidazole, azido, hydrazino, hydroxylamino, isocyanato, sulfoxide, sulfone, sulfide, disulfide, silyl, aryl, heterocycle, carbocycle, intercalator, reporter molecule, conjugate, polyamine, polyamide, polyalkylene glycol, polyether, a group that enhances the pharmacodynamic properties of oligonucleotides, a group that enhances the pharmacokinetic properties of oligonucleotides, or a group of formula (—O—X1)p, where p is 2 to about 10 and X3 is alkyl having from one to about 10 carbons;
- B is a naturally occurring or non-naturally occurring nucleobase that is optionally protected and optionally radiolabeled;
- comprising the steps of:
- providing a compound having the Formula II:
- 33
- wherein:
- R3 is hydrogen, a hydroxyl protecting group, or a linker connected to a solid support;
- M is an optionally protected internucleotide linkage;
- each B, independently is a naturally occurring or non-naturally occurring nucleobase that is optionally protected and optionally radiolabeled;
- n is 0 to about 50;
- R5 is —N(R)6,2 or a heterocycloalkyl or heterocycloalkenyl ring containing from 4 to 7 atoms and up to 3 heteroatoms selected from nitrogen, sulfur, and oxygen;
- R6 is straight or branched chain alkyl having from 1 to 10 carbons;
- and
- reacting the compound of Formula II with a compound having Formula III:
- 34
- wherein:
- R3a is hydrogen;
- m is 0 to about 50;
- R2 is a hydroxyl protecting group, or a linker connected to a solid support, provided that R2 and R3 are not both simultaneously a linker connected to a solid support;
- thereby forming the oligomeric compound.
27 more elements
A method for preparing a phosphoramidite of Formula:
- 42
- wherein:
- R3 is hydrogen, a hydroxyl protecting group, or a linker connected to a solid support;
- Z is aryl having 6 to about 14 carbon atoms or alkyl having from one to about six carbon atoms;
- Y1 is O or S;
- Y2 is O or S;
- Y3 is C(═O) or S;
- q is 2 to about 4;
- M is an optionally protected internucleotide linkage;
- each B, independently is a naturally occurring or non-naturally occurring nucleobase that is optionally protected and optionally radiolabeled;
- n is 0 to about 50;
- R1 is H, OH, F, or a group of formula R7—(R8)n;
- R7 is C3-C20 alkyl, C4-C2, alkenyl, C2-C20 alkynyl, C1-C20 alkoxy, C2-C20 alkenyloxy, or C2-C20 alkynyloxy;
- R8 is hydrogen, amino, protected amino, halogen, hydroxyl, thiol, keto, carboxyl, nitro, nitroso, nitrile, trifluoromethyl, trifluoromethoxy, O-alkyl, S-alkyl, NH-alkyl, N-dialkyl, O-aryl, S-aryl, NH-aryl, O-aralkyl, S-aralkyl, NH-aralkyl, N-phthalimido, imidazole, azido, hydrazino, hydroxylamino, isocyanato, sulfoxide, sulfone, sulfide, disulfide, silyl, aryl, heterocycle, carbocycle, intercalator, reporter molecule, conjugate, polyamine, polyamide, polyalkylene glycol, polyether, a group that enhances the pharmacodynamic properties of oligonucleotides, a group that enhances the pharmacokinetic properties of oligonucleotides, or a group of formula (—O—X3)p, where p is 1 to about 10 and X3 is alkyl having from one to about 10 carbons;
- R5 is —N(R6)2, or a heterocycloalkyl or heterocycloalkenyl ring containing from 4 to 7 atoms and up to 3 heteroatoms selected from nitrogen, sulfur, and oxygen;
- R6 is straight or branched chain alkyl having from 1 to 10 carbons;
- comprising the steps of:
- providing a compound Formula:
- 43
- and reacting the compound with a diaminohalophosphine of Formula:
- 44
- wherein X is halogen;
- thereby providing a phosphordiamidite of Formula:
- 45
- and
- contacting the nucleoside phosphordiamidite with a reagent of Formula XX:
- 46
- to produce the phosphoramidite.
25 more elements
A method for preparing a phosphoramidite of Formula:
- 48
- wherein:
- R3 is hydrogen, a hydroxyl protecting group, or a linker connected to a solid support;
- Z is aryl having 6 to about 14 carbon atoms or alkyl having from one to about six carbon atoms;
- Y1 is O or S;
- Y2 is O or S;
- Y3 is C(═O) or S;
- M is an optionally protected internucleotide linkage;
- each B, independently is a naturally occurring or non-naturally occurring nucleobase that is optionally protected and optionally radiolabeled;
- n is 0 to about 50;
- R1 is H, OH, F, or a group of formula R7—(R8)n;
- R7 is C3-C10 alkyl, C4-C20 alkenyl, C2-C29 alkynyl, C1-C20 alkoxy, C2-C20 alkenyloxy, or C2-C20 alkynyloxy;
- R8 is hydrogen, amino, protected amino, halogen, hydroxyl, thiol, keto, carboxyl, nitro, nitroso, nitrile, trifluoromethyl, trifluoromethoxy, O-alkyl, S-alkyl, NH-alkyl, N-dialkyl, O-aryl, S-aryl, NH-aryl, O-aralkyl, S-aralkyl, NH-aralkyl, N-phthalimido, imidazole, azido, hydrazino, hydroxylamino, isocyanato, sulfoxide, sulfone, sulfide, disulfide, silyl, aryl, heterocycle, carbocycle, intercalator, reporter molecule, conjugate, polyamine, polyamide, polyalkylene glycol, polyether, a group that enhances the pharmacodynamic properties of oligonucleotides, a group that enhances the pharmacokinetic properties of oligonucleotides, or a group of formula (—O—X3)p, where p is 1 to about 10 and X3 is alkyl having from one to about 10 carbons;
- R5 is —N(R6)2, or a heterocycloalkyl or heterocycloalkenyl ring containing from 4 to 7 atoms and up to 3 heteroatoms selected from nitrogen, sulfur, and oxygen;
- R6 is straight or branched chain alkyl having from 1 to 10 carbons;
- comprising the steps of:
- providing a compound Formula:
- 49
- and reacting the compound with a compound of Formula:
- 50
- wherein:
- R5 is —N(R)6,2 or a heterocycloalkyl or heterocycloalkenyl ring containing from 4 to 7 atoms and up to 3 heteroatoms selected from nitrogen, sulfur, and oxygen;
- R6 is straight or branched chain alkyl having from 1 to 10 carbons;
- thereby producing the phosphordiamidite.
21 more elements
Dependencies are inferred from the claim text.